Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Rivaroxaban × Myeloid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 7 Myeloid 1

Conditions

Myeloproliferative Disorders 1

Interventions

Blood Specimen Collection 15 Imatinib Mesylate 8 Flow Cytometry 8 Surveys and Questionnaires 7 Polymerase Chain Reaction 7 ruxolitinib 5 ponatinib 5 nilotinib 5 Dasatinib 5 Therapeutics 4 Interviews as Topic 4 Cytogenetic Analysis 4 bosutinib 3 Psychiatric Rehabilitation 3 Biopsy 3 olverembatinib 2 Watchful Waiting 2 Observation 2 Microarray Analysis 2 Immunologic Techniques 2 Immunoenzyme Techniques 2 Hydroxyurea 2 High-Energy Shock Waves 2 Gene Expression Profiling 2 Data Collection 2 Bone Marrow Transplantation 2 Azacitidine 2 Amplified Fragment Length Polymorphism Analysis 2 venetoclax 1 quizartinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04192916 2021-02-21

MPN-DOACs

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡